New class of cancer drugs down, not out, after Roche trial setback – analysts

, , , , , , , , ,
Roche

New class of cancer drugs down, not out, after Roche trial setback – analysts

 

Reuters source:

https://www.reuters.com/business/healthcare-pharmaceuticals/new-class-cancer-drugs-down-not-out-after-roche-trial-setback-analysts-2022-05-11